Pacira BioSciences 

$13.85
16
-$0.83-5.65% Friday 20:00

Statistik

Harga Tertinggi Hari
14.9
Harga Terendah Hari
13.77
52M Tertinggi
35.95
52M Terendah
11.16
Volum
825,443
Volum Purata
1,364,014
Kapasiti Pasaran
717.73M
Nisbah P/E
11.61
Pendapatan Dividen
-
Dividen
-

Akan Datang

Pendapatan

31OctDijangka
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Seterusnya
0.53
0.65
0.77
0.89
EPS yang dijangka
0.724889
EPS sebenar
N/A

Orang Lain Juga Mengikuti

Senarai ini berdasarkan senarai pantau orang di Stock Events yang mengikuti PCRX. Ini bukan cadangan pelaburan.

Peserta

Senarai ini adalah analisis berdasarkan peristiwa pasaran terkini. Ini bukan cadangan pelaburan.

Penilaian Penganalisis

24.63$Sasaran Harga Purata
Anggaran tertinggi adalah $42.
Dari 8 penilaian dalam tempoh 6 bulan terakhir. Ini bukan cadangan pelaburan.
Beli
50%
Pegang
25%
Jual
25%

Mengenai

Health Technology
Pharmaceuticals: Other
Manufacturing
Pharmaceutical Preparation Manufacturing
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.
Show more...
CEO
David M. Stack
Pekerja
711
Negara
US
ISIN
US6951271005

Penyenaraian